The short answer
Cyclists do not need one universal blood panel.
A blood test is useful when it answers a defined question: investigating persistent symptoms, checking a plausible deficiency, monitoring a diagnosed condition or medicine, or following ordinary preventive-health guidance. The reason for testing determines the markers, timing and frequency.
For persistent unexplained fatigue, a clinician may consider a full blood count, ferritin with other iron indices, thyroid testing or other investigations after taking a history and examining the rider. The persistent cycling fatigue guide explains when that assessment should happen.
Do not substitute an “athlete optimal ranges” table for diagnosis. Ferritin, haemoglobin, CRP, thyroid hormones, testosterone, cortisol and white cells all need context. No one value diagnoses overtraining, REDs or readiness.
Start with the question, not the panel
The same tired legs can sit beside very different problems. A test list should follow the clinical question.
| Question | What may be considered | What the result cannot do alone |
|---|---|---|
| Is anaemia or iron deficiency plausible? | Full blood count and an iron assessment that may include ferritin and transferrin saturation | Diagnose the cause or justify self-directed iron treatment |
| Is thyroid dysfunction suspected? | For most adults without suspected pituitary disease, TSH first with further tests according to the result | Create an athlete-only thyroid diagnosis from a low-normal value |
| Are symptoms compatible with male hypogonadism? | Accurate morning testing, repeat confirmation and cause-focused evaluation | Turn age, fatigue or one low value into a testosterone diagnosis |
| Is problematic low energy availability possible? | Clinical REDs assessment; selected health, nutrition and laboratory information | Diagnose REDs from ferritin, T3, testosterone or cortisol alone |
| Is inflammation, infection or another illness suspected? | Tests selected from the symptoms, history and examination | Use CRP or white cells as a recovery score |
| Is this preventive cardiovascular or metabolic care? | Lipids, glucose or HbA1c according to age, risk, medicines and local guidance | Promise cycling performance gains from “optimising” every result |
| Is a known condition being monitored? | The tests and schedule specified by the treating clinician | Replace clinical follow-up with a private dashboard |
This framework produces fewer tests but better decisions.
More testing is not automatically better
In a study of 50 elite athletes presenting with short-term fatigue, a standard blood panel changed the diagnosis reached after history and examination in only one case. Athletes and coaches nevertheless had very high expectations of blood testing even for fatigue lasting less than a week.
Screening can also create noise. A study of routine biochemical screening in 100 elite athletes found many abnormal results, but relatively few persistent findings with clear clinical importance.
That does not make blood tests useless. It means:
- symptoms and history determine the starting probability;
- a broad panel produces incidental and borderline findings;
- an abnormal result may need confirmation rather than immediate treatment;
- a normal result does not explain every symptom; and
- someone must own interpretation and follow-up before the sample is taken.
Clinical ranges do not “lie” to athletes
A laboratory reference interval describes how that laboratory and assay classify results in a reference population. It is not a promise of perfect health or performance, but neither is it a range designed simply for sedentary people.
Athlete context can matter. Training can alter plasma volume; exercise, hydration, illness, food, time of day and medicines can affect selected markers. The answer is not to discard clinical intervals and invent one universal “optimal” column. It is to interpret the measured value with:
- the reporting laboratory and assay;
- symptoms, sex, age, health history and medicines;
- recent exercise, illness, hydration and nutrition;
- relevant athlete-specific risk;
- previous comparable results; and
- evidence that the proposed action improves a meaningful outcome.
The performance target belongs in the training plan. A diagnostic threshold belongs with the clinician and laboratory.
Full blood count: useful, not an overtraining detector
A full blood count—often FBC in the UK and CBC elsewhere—reports haemoglobin, haematocrit, red-cell indices, white cells and platelets. It can reveal a pattern that supports investigation of anaemia, infection, bleeding, nutritional deficiency or another condition.
It cannot diagnose “early overtraining.”
Endurance training can expand plasma volume, making haemoglobin concentration and haematocrit appear lower without a reduction in total red-cell mass. Hydration, altitude, illness and laboratory variation also matter. White-cell changes are nonspecific. A result needs the rest of the picture rather than a label such as “suppressed immunity” or “systemic stress.”
The overtraining consensus does not identify an accepted diagnostic blood marker. A later diagnostic scoping review reached the same practical boundary: proposed tests do not provide a gold-standard OTS diagnosis.
Iron and ferritin: assess the pattern and the risk
Iron deficiency and iron-deficiency anaemia can impair health and endurance performance. Cyclists may have relevant risks including menstruation, frequent blood donation, inadequate intake, gastrointestinal disease or bleeding, previous deficiency and high training demands.
Ferritin is useful, but it is not the whole diagnosis. It is also an acute-phase protein and can rise with inflammation. The athlete iron framework described by Sim and colleagues combines risk factors, symptoms, standardised collection and multiple indices rather than relying on one number. Haemoglobin and transferrin saturation may be interpreted alongside ferritin; the appropriate assessment depends on the case.
There is no evidence-based 50–150 ng/mL performance target for every cyclist. Decision thresholds used in elite-sport frameworks are not a licence to treat all low-normal results, and ferritin cannot tell you why iron is low.
If iron deficiency is confirmed, the clinician should consider the cause and the treatment. Do not start iron because a forum, app or coach says your ferritin is “suboptimal.” Excess iron is harmful, treatment can cause side effects, and unexplained deficiency may need investigation.
Use the cyclist iron guide for the narrower evidence and decision pathway.
Thyroid testing: more markers are not always more accurate
Fatigue, weight change, cold intolerance, palpitations and other symptoms can contribute to a clinician's decision to investigate thyroid dysfunction. Those symptoms are nonspecific, so the test strategy matters.
NICE guideline NG145 recommends measuring TSH alone first for most adults when secondary thyroid dysfunction is not suspected. If TSH is above the reference interval, FT4 is measured in the same sample; if TSH is below it, FT4 and FT3 are measured. When pituitary disease is suspected, the pathway is different.
NICE also says not to test during an acute illness unless the illness itself may be due to thyroid dysfunction, because acute illness can affect results. It specifically tells clinicians to ask about biotin supplements, which can produce falsely high or low thyroid results.
Roadman cannot safely replace this with “TSH 0.5–2.5 is optimal” or “TSH above 3.0 is a red flag.” Use the reporting laboratory, the clinical pathway and repeat testing where indicated.
Testosterone: symptoms plus repeat confirmation
Testosterone varies with time of day, energy availability, illness, sleep, medication and measurement method. Ageing changes the distribution, but age and cycling do not diagnose hypogonadism.
The Endocrine Society clinical practice guideline recommends diagnosing male hypogonadism only when compatible symptoms and signs occur with unequivocally and consistently low testosterone concentrations. It recommends confirming the result with a repeat morning fasting total-testosterone measurement and then evaluating the cause.
One low test after a hard block is not a diagnosis. A universal 15–25 nmol/L “athletic optimal” target is not established. Free testosterone can be useful in selected circumstances, but assay quality, SHBG and clinical context matter.
Do not use testosterone treatment as a performance correction. It has medical risks, can affect fertility and is prohibited in sport without the required therapeutic-use authorisation.
Cortisol and the cortisol-to-testosterone ratio
Morning cortisol has valid clinical uses, including investigation of suspected adrenal disease. It is not a general stress score.
Cortisol varies with circadian timing, illness, sleep, energy availability, psychological stress and exercise. A cortisol-to-testosterone ratio is not a validated diagnostic test for overreaching or OTS and cannot say whether today's intervals are safe.
Blood markers can help investigate other conditions in a persistently underperforming rider. They do not convert the complex distinction between functional overreaching, non-functional overreaching and OTS into one ratio. Use the overreaching-versus-overtraining owner for that comparison.
CRP: inflammation marker, not a readiness zone
C-reactive protein is nonspecific. Infection, injury, inflammatory disease, body composition and exercise can affect it. A systematic review of inflammatory responses to exercise reported CRP increases after both intense and moderate exercise, with timing varying across studies.
Values commonly quoted as low, moderate and high cardiovascular risk were developed for a different decision. They are not cycling-recovery zones. “CRP above 3 mg/L means do not train” is not a validated rule.
If a clinician orders CRP, interpret it for the reason it was ordered. An unexpected elevation may need repeat or further assessment; it does not name the cause.
Vitamin D, B12, folate and other add-ons
Vitamin or micronutrient tests can be useful when symptoms, diet, medicines, bone health, malabsorption or another risk makes deficiency plausible. They do not belong automatically in every athlete panel.
Serum 25(OH)D is the main vitamin D status marker, but no universal athlete-performance target is established. Routine population testing and treatment recommendations also differ by country and risk group. The reviewed vitamin D guide for cyclists covers the NHS, NIH and athlete evidence without turning an upper safety ceiling into a daily dose.
Private panel add-ons create the same responsibility as any other test: know what question is being asked, how a result will be confirmed and who will treat a genuine abnormality.
REDs is not one low hormone or nutrient result
Low energy availability can affect reproductive, endocrine, bone, immune, haematological and performance outcomes. That makes blood results part of some REDs assessments, but it does not make one value diagnostic.
The 2023 IOC REDs consensus describes a multifactorial clinical syndrome and introduces a structured clinical assessment tool. Symptoms, behaviours, health effects, severity and risk modifiers are considered together by an appropriately qualified team.
Do not diagnose REDs because T3, testosterone, ferritin or vitamin D is low. Do not rule it out because a panel is normal. Use the REDs guide for cyclists and qualified clinical and nutrition care.
How to prepare for a cyclist blood test
Preparation depends on the test. Follow the clinician and laboratory instructions rather than applying one athlete ritual to everything.
For a planned comparison or monitoring test, record:
- date and time of sample;
- whether fasting was requested and the actual fast duration;
- recent training, including racing or muscle-damaging exercise;
- hydration and any unusual heat exposure;
- current illness, infection or injury;
- medicines and supplements, including biotin and iron;
- menstrual-cycle context where it is clinically relevant; and
- altitude exposure, blood donation or recent travel.
A 2023 sports-medicine review explains why workload biomarkers require careful collection and interpretation. Consistent conditions can improve longitudinal comparison, but “fasted morning, recovery week, same lab” is not a universal rule for every clinical test.
Important exceptions:
- if the clinician wants to investigate symptoms during a specific state, that timing may be intentional;
- do not delay urgent assessment to create a clean baseline;
- do not fast unless instructed;
- do not stop a prescribed medicine or supplement without advice; and
- repeat confirmation may be more appropriate than acting on a surprising result.
How often should cyclists test blood?
There is no evidence-based minimum of twice yearly for every cyclist, and being over 40 does not automatically require three athlete panels a year.
Frequency should reflect:
- symptoms and medical history;
- previous abnormal or borderline results;
- a diagnosed condition or medicine-monitoring plan;
- ordinary age- and risk-based preventive care;
- iron risk such as heavy menstrual bleeding, blood donation, dietary restriction or previous deficiency;
- elite or high-performance programme requirements; and
- whether a repeat result will change a decision.
The athlete iron literature supports risk-based screening rather than one schedule for all. A high-performance rider with prior iron deficiency and a rider commuting three days a week do not need the same monitoring plan.
The result-review checklist
Before changing training, supplements or treatment, answer these questions:
- Why was this marker ordered?
- Was the result inside or outside the reporting laboratory's interval?
- Could recent exercise, illness, hydration, timing, medicine or supplements affect it?
- Does the result fit the symptoms and other markers?
- Is repeat confirmation required?
- What important causes need assessment?
- Who is qualified to recommend treatment?
- What outcome and follow-up interval will show whether the plan worked?
One isolated result may be important. A trend can be more informative. Neither should be interpreted without measurement quality and clinical context.
What the Roadman app can—and cannot—do
A recovery system can store the test date, result, reporting interval and the training, sleep, illness and symptom context around it. It can help a rider arrive at an appointment with a coherent timeline and avoid comparing two samples as though they were collected under identical conditions when they were not.
It cannot diagnose anaemia, thyroid disease, hypogonadism, REDs, infection, inflammation or OTS. It should not label a result “athletically deficient,” recommend iron or hormones, or turn CRP and testosterone into a readiness score.
Roadman is building the product around that boundary: useful longitudinal context and better training decisions while diagnosis and treatment stay with qualified care. Join the single app waiting list for launch access.
The Roadman decision
If you are healthy, training normally and have no specific risk or preventive-health indication, do not buy a giant panel simply because you ride a bike.
If fatigue is persistent, unexplained, recurrent or affecting daily life, get assessed. The clinician may use targeted blood tests as part of that process.
If a result is abnormal, do not jump from flag to supplement. Confirm what the result means, investigate the cause and agree follow-up.
The best blood test is not the one with the most markers. It is the one that changes the right decision.